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Background
Abscesses are often successfully treated with antimicro-
bial agents when drainage is not feasible, but appropri-
ate data on antibiotic abscess penetration in humans are
missing. This study aimed at evaluating and comparing
pharmacokinetics of cefpirome and moxifloxacin in the
same abscesses to evaluate their eligibility for this
indication.
Methods
After simultaneous administration of 2 g cefpirome and
400 mg moxifloxacin to patients drug levels were mea-
sured in plasma over 8 h, and in differently located
abscesses (n = 12) at incision. A population pharmacoki-
netic analysis and a two-stage model were applied. The
impact of abscess morphology and plasma levels on
antibiotic abscess penetration was investigated.
Results
At incision performed 158 ± 112 min after administra-
tion, cefpirome concentrations in abscess ranged from
below the limit of quantification to 47 mg/L (8.4 ±
14.1 mg/L), and moxifloxacin concentrations ranged
from below the limit of quantification to 9.2 mg/L
(1.9 ± 3.4 mg/L). Relative to plasma, abscess concentra-
tions of moxifloxacin were significantly higher than of
cefpirome (p = 0.037). Inhibitory concentrations of both
antibiotics reported for abscess-relevant bacterial species
were reached in several, but not in all abscess observa-
tions. Antibiotic abscess penetration could not be
adequately explained considering covariates such as pH
of abscess fluid, or the ratio of surface area to volume of
abscesses, linked to plasma pharmacokinetics.
Conclusions
Cefpirome and moxifloxacin were detectable in most
a b s c e s s e sa f t e ras i n g l ed o s ea n dm i g h tb ee l i g i b l ei f
conservative treatment is required. However, antibiotic
abscess penetration was highly variable and unpredict-
able, and clinicians should anticipate insufficient drug
levels in some cases.
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